Live Chat ×
Skip to main content

Predicting human milk/plasma (M/P) concentration ratios of small-molecule drugs and therapeutic antibody

Thank you

This live web event has ended. Thank you for attending.


  • Peng Zou, Ph.D.

    Peng Zou, Ph.D., is currently a chemistry reviewer at the Immediate Office, Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research, FDA. He received his Ph.D. in pharmaceutical sciences from the University of Michigan in 2011 and then did his postdoc training at the National Cancer Institute in Maryland. Zou joined the FDA Office of Generic Drugs in 2012 and was responsible for CMC review of nanoparticle products such as iron colloids and liposomes. His current work at OPQ focuses on CMC review of complex ANDA products, PBPK modeling of complex drug products, and internal/external grant management. He has published 40 journal articles and book chapters and has been a co-inventor for three US patents.

May 7, 2020
Thu 12:30 PM EDT

Duration 1H 30M

This live web event has ended.